Neurocrine Biosciences
NBIX
#1519
Rank
ยฃ8.71 B
Marketcap
ยฃ87.37
Share price
-0.74%
Change (1 day)
-20.02%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) Fails to deliver data

Key failure to deliver metrics for Neurocrine Biosciences :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Neurocrine Biosciences (NBIX) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Neurocrine Biosciences (NBIX) - since 2013

Volume in USD (price x number of shares), data since 2013

Neurocrine Biosciences (NBIX) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025ยฃ7.76 M-68.42%
2024ยฃ24.58 M12.15%
2023ยฃ21.91 M-32.24%
2022ยฃ32.34 M-26.75%
2021ยฃ44.16 M193.08%
2020ยฃ15.06 M-65.24%
2019ยฃ43.34 M-3.16%
2018ยฃ44.76 M-18.56%
2017ยฃ54.96 M78.43%
2016ยฃ30.8 M53.41%
2015ยฃ20.07 M66.9%
2014ยฃ12.03 M241.08%
2013ยฃ3.52 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
ยฃ6.38 Mยฃ34.95 M๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ16.72 Mยฃ42.88 M๐Ÿ‡ฌ๐Ÿ‡ง UK
ยฃ0.73 Mยฃ3.94 M๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ70.56 Mยฃ0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ34.68 Mยฃ0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ32.79 Mยฃ0.34 B๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.21 Mยฃ4.52 M๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.09 Mยฃ0.71 M๐Ÿ‡บ๐Ÿ‡ธ USA